PL442547A1 - Pochodne 4-arylotiosemikarbazydu do zastosowania w leczeniu toksoplazmozy - Google Patents

Pochodne 4-arylotiosemikarbazydu do zastosowania w leczeniu toksoplazmozy

Info

Publication number
PL442547A1
PL442547A1 PL442547A PL44254722A PL442547A1 PL 442547 A1 PL442547 A1 PL 442547A1 PL 442547 A PL442547 A PL 442547A PL 44254722 A PL44254722 A PL 44254722A PL 442547 A1 PL442547 A1 PL 442547A1
Authority
PL
Poland
Prior art keywords
arylthiosemicarbazide
toxoplasmosis
derivatives
treatment
syrup
Prior art date
Application number
PL442547A
Other languages
English (en)
Inventor
Katarzyna Dzitko
Adrian Bekier
Justyna Gatkowska
Maciej Chyb
Original Assignee
Uniwersytet Łódzki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Łódzki filed Critical Uniwersytet Łódzki
Priority to PL442547A priority Critical patent/PL442547A1/pl
Publication of PL442547A1 publication Critical patent/PL442547A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Przedmiotem zgłoszenia są pochodne 4-arylotiosemikarbazydu o wzorze 2a i 6a do zastosowania w leczeniu toksoplazmozy w postaci tabletek, proszku, granulek, kapsułek, syropu oraz roztworu do wstrzykiwania.
PL442547A 2022-10-18 2022-10-18 Pochodne 4-arylotiosemikarbazydu do zastosowania w leczeniu toksoplazmozy PL442547A1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL442547A PL442547A1 (pl) 2022-10-18 2022-10-18 Pochodne 4-arylotiosemikarbazydu do zastosowania w leczeniu toksoplazmozy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL442547A PL442547A1 (pl) 2022-10-18 2022-10-18 Pochodne 4-arylotiosemikarbazydu do zastosowania w leczeniu toksoplazmozy

Publications (1)

Publication Number Publication Date
PL442547A1 true PL442547A1 (pl) 2024-04-22

Family

ID=90790600

Family Applications (1)

Application Number Title Priority Date Filing Date
PL442547A PL442547A1 (pl) 2022-10-18 2022-10-18 Pochodne 4-arylotiosemikarbazydu do zastosowania w leczeniu toksoplazmozy

Country Status (1)

Country Link
PL (1) PL442547A1 (pl)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL426156A1 (pl) * 2018-06-29 2020-01-02 Uniwersytet Medyczny W Lublinie Pochodne 4-jodofenylo-1-(4-metyloimidazol-5-ilo)tiosemikarbazydu, sposób ich wytwarzania i zastosowanie medyczne

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL426156A1 (pl) * 2018-06-29 2020-01-02 Uniwersytet Medyczny W Lublinie Pochodne 4-jodofenylo-1-(4-metyloimidazol-5-ilo)tiosemikarbazydu, sposób ich wytwarzania i zastosowanie medyczne

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEKIER A. I IN.: "J Enzyme Inhib Med Chem. 2021 Dec;36(1):1145-1164. doi: 10.1080/14756366.2021.1931164", "4-ARYLTHIOSEMICARBAZIDE DERIVATIVES AS A NEW CLASS OF TYROSINASE INHIBITORS AND ANTI-TOXOPLASMA GONDII AGENTS" *
PANETH A. I IN.: "Molecules. 2019 Apr 24;24(8):1618. doi: 10.3390/molecules24081618", "DISCOVERY OF POTENT AND SELECTIVE HALOGEN-SUBSTITUTED IMIDAZOLE-THIOSEMICARBAZIDES FOR INHIBITION OF TOXOPLASMA GONDII GROWTH IN VITRO VIA STRUCTURE-BASED DESIGN" *
PANETH A. I IN.: "Molecules. 2019 Feb 10;24(3):614. doi: 10.3390/molecules24030614", "SYSTEMATIC IDENTIFICATION OF THIOSEMICARBAZIDES FOR INHIBITION OF TOXOPLASMA GONDII GROWTH IN VITRO" *

Similar Documents

Publication Publication Date Title
CY1125292T1 (el) Παραγωγα 6,7,8,9-tetpaϋδpo-3h-πypazoλo[4,3-f iσοκινολινης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου
GEAP202315703A (en) Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer
FI3788047T3 (fi) Fgft-estäjän kiinteitä muotoja ja menetelmiä niiden valmistamiseksi
JOP20200154B1 (ar) مركبات ومشتقات بيريدو بيريمينون بها استبدال ببنزيل أمينو جديدة كمثبطات sos1
JOP20220163B1 (ar) مركب بيريدازينيل-ثيازول كربوكساميد
ZA202201364B (en) Deuterated compounds for use in the treatment of cancer
EA201891049A1 (ru) Изоиндолиновые, азаизоиндолиновые, дигидроинденоновые и дигидроазаинденоновые ингибиторы mnk1 и mnk2
PH12017502246A1 (en) New hydroxyester derivatives, a process for their preparation and pharmaceutical compositions containing them
MX2019011530A (es) Saxitoxinas 11,13-modificadas para el tratamiento del dolor.
EA201001368A1 (ru) Гетероциклические производные мочевины и способы их применения-211
EA201100971A1 (ru) Производные пиримидининдола для лечения злокачественного новообразования
EA201990643A1 (ru) Фармацевтические соединения
UY30819A1 (es) Derivados de pirazol, composiciones farmacéuticas conteniéndolos, procesos de preparacion y aplicaciones
EA201691151A1 (ru) Соединения для лечения пациентов с ros1-мутантными раковыми клетками
UY30472A1 (es) Nuevos derivados de pirimidina, procesos para su preparacion composiciones farmacéuticas conteniédolos, procesos para su preparacion y aplicaciones.
MX2015012760A (es) Composicion farmaceutica que comprende un activador de ampk y un agente serotonergico y metodos de uso de la misma.
ECSP109935A (es) Derivados de morfolino pirimidina utilizados en enfermedades relacionadas con mtor quinasa y/o pi3k
NZ748946A (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
PL417066A1 (pl) Inhibitory arginazy oraz ich zastosowania terapeutyczne
EA201070327A1 (ru) Катехоламиновые производные и их пролекарства
BR112017007708A2 (pt) composto macrocíclicos, uso de um composto macrocíclicos, método para tratamento, unidade de dose, composição farmacêutica e método para tratar câncer em um paciente
WO2017087808A8 (en) Heterocyclic compounds that inhibit the kinase activity of mnk useful for treating various cancers
MX2020006594A (es) Inhibidores de exo-azaespiro de la interaccion menina-mll.
EA201891050A1 (ru) Соединения пирроло-, пиразоло-, имидазопиримидина и пиридина, которые ингибируют mnk1 и mnk2
CL2011001860A1 (es) Compuestos derivados de indol; procedimiento de preparacion de dichos compuestos; composicion y combinacion farmaceutica; y uso en el tratamiento del cancer.